1Cooper E, Vernon J. The effectiveness of pharmacological ap- proaches in the treatment of alcohol withdrawal syndrome (AWS) :a literature review[J]. J Psychiatr Ment Health Nurs, 2013,20(7) :601-612.
2Eates L E. Alcohol withdrawal syndrome in trauma patients a review [J]. J Emerg Nurs,2010,36(5) :507-509.
4Rujeseu D,Soyka M,Dahmen N,et al. GRIN1 locus may modi fy the susceptibility to seizures during alcohol withdrawal[J]. Am J Med Genet B Neuropsychiatry Genet, 2005,133B(1) :85 87.
6Hillemacher T,Bayerlein K, Frieling H, et al. Elevated prolac tin serum levels and history of alcohol withdrawal seizures[J]. J Psychiatr Res,2007,41(8) ,702-706.
7Bleieh S, Bayerlein K, Reulbach U, et al. Homocysteine levels in patients classified according to Lesch's typology[J]. Alcohol and Alcoholism, 2004,39 (6) : 493-498.
8Clements J D. Transmitter timecourse in the synaptic cleft:its role in central synaptic function[J]. Trends Neurosci, 1996,19 (5):163 171.
9LaRoche S M,Shivdat Nanhoe R. Subacute encephalopathy and seizures in alcoholics (SESA) presenting with non-convulsive status epilepticus [J]. Seizure,2011,20(6):505-508.
6Schrattenholz A, Soskic V. NMDA receptors are not alone: dynamic regulation of NMDA receptor structure and function by neuregulins and transient cholesterol-rich membrane domains leads to disease-specific nuances of glutamate-signalling. Curt Top Med Chem, 2006, 6 (7) : 663-686.
7Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits : diversity, development and disease. J Curt Opin Neurobiol, 2001, 11(3) : 327-335.
8Chatterton JE, Awobuluyi M, Premkumar LS, et al. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature, 2002 , 415 ( 6873 ) : 793 -798.
9Madry C, Mesic I, Bartholom ? us I, et al : Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function. Biochem Biophys Res Commun, 2007, 354 ( 1 ) : 102-108.
10Wada A, Takahashi H, Lipton SA, et al. NR3A modulates the outer vestibule of the " NMDA" receptor channel. J Neurosci, 2006, 26(51) : 13156-13166.
6Luijckx GJ, Nieuwhof C, Troost J, et al. Parkinsonism in alcohol withdrawal: case report and review of the literature[J]. Clin Neurol Neurosurg, 1995, 97(4): 336-339.
7Brust JC. Substance abuse and movement disorders[J]. Mov Disord, 2010, 25(13): 2010-2020.
8Sivolap IuP, Damulin IV, Mendelevich SV, et al. [Mental disorders following delirium tremens] [J]. Zh Nevrol Psikhiatr Im S S Korsakova, 2011, 111(11 Pt 2): 28-29.
9Deik A, Saunders-Pullman R, Luciano MS. Substance abuse and movement disorders: complex interactions and comorbidities [J]. Curr Drug Abuse Rev, 2012, 5(3): 243-253.
10Eriksson AK, Lofving S, Callaghan RC, et al. Alcohol use disorders and risk of Parkinson's disease: findings from a Swedish national cohort study 1972-2008[J]. BMC Neurol, 2013, 13(12): 190.
